Nandini Apurva Vyas

Nandini Apurva Vyas

Director Partner DIN 07378813
DIN 07378813 First appointment Jan 2016 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 3 historical roles
Total affiliations 3 Since Jan 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Nandini Apurva Vyas

Data last updated:

Nandini Apurva Vyas was a Partner at Anac Healthcare Llp (2019–2020), Director at Ansh Laproscopic Private Limited (from 2016) and Designated Partner at Nrg Super Specialty Clinic Llp (from 2018). The companies operate in Pharma.

DIN 07378813
Primary Designation Partner
Industry Pharma
First Appointment 18 Jan 2016
Oldest Company Age 10 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Partner22 Nov 20192019Active
Ansh Laproscopic Private Limited U85110GJ2016PTC085737
Director18 Jan 20162016₹3,680 (FY 2019)Strike Off
Designated Partner25 Sep 20182018Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ansh Laproscopic Private Limited
Nrg Super Specialty Clinic Llp
Anac Healthcare Llp
Premium access

Shareholding and investment profile for Nandini Apurva Vyas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nandini Apurva Vyas

Nandini Apurva Vyas was first appointed on 18 Jan 2016 as Director at Ansh Laproscopic Private Limited. The most recent appointment on record is 22 Nov 2019 at Anac Healthcare Llp.

Nandini Apurva Vyas held 3 earlier board appointments: Anac Healthcare Llp (Partner, 22 Nov 2019 to 15 Oct 2020); Ansh Laproscopic Private Limited (Director, from 18 Jan 2016); Nrg Super Specialty Clinic Llp (Designated Partner, from 25 Sep 2018).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available